We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Vor Biopharma Inc | NASDAQ:VOR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.01 | -0.76% | 1.31 | 1.29 | 1.37 | 1.36 | 1.29 | 1.33 | 178,795 | 01:00:00 |
JMP Securities Hematology and Oncology SummitFireside Chat: Tuesday, December 5, 2023 at 1:30 pm ET Location: Virtual
About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com
1 Year Vor Biopharma Chart |
1 Month Vor Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions